| pubmed-article:3493057 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:3493057 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:3493057 | lifeskim:mentions | umls-concept:C0027814 | lld:lifeskim |
| pubmed-article:3493057 | lifeskim:mentions | umls-concept:C0032950 | lld:lifeskim |
| pubmed-article:3493057 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:3493057 | pubmed:dateCreated | 1987-4-23 | lld:pubmed |
| pubmed-article:3493057 | pubmed:abstractText | Experimental allergic neuritis (EAN) in Lewis rats was treated with prednisolone given prophylactically or therapeutically. Rats treated from the time of immunization with myelin or after the establishment of clinical disease improved more rapidly than controls. Treatment at the onset of clinical signs resulted in less severe disease and more rapid recovery. Rats treated just prior to the onset of clinical signs (day 10) did not develop significant clinical disease and appeared to have less inflammation in their nerves and nerve roots on microscopic examination. | lld:pubmed |
| pubmed-article:3493057 | pubmed:language | eng | lld:pubmed |
| pubmed-article:3493057 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3493057 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:3493057 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3493057 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:3493057 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:3493057 | pubmed:issn | 0317-1671 | lld:pubmed |
| pubmed-article:3493057 | pubmed:author | pubmed-author:GilbertJ JJJ | lld:pubmed |
| pubmed-article:3493057 | pubmed:author | pubmed-author:FeasbyT ETE | lld:pubmed |
| pubmed-article:3493057 | pubmed:author | pubmed-author:HaleC GCG | lld:pubmed |
| pubmed-article:3493057 | pubmed:author | pubmed-author:LovgrenD SDS | lld:pubmed |
| pubmed-article:3493057 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:3493057 | pubmed:volume | 14 | lld:pubmed |
| pubmed-article:3493057 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:3493057 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:3493057 | pubmed:pagination | 46-9 | lld:pubmed |
| pubmed-article:3493057 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:3493057 | pubmed:meshHeading | pubmed-meshheading:3493057-... | lld:pubmed |
| pubmed-article:3493057 | pubmed:meshHeading | pubmed-meshheading:3493057-... | lld:pubmed |
| pubmed-article:3493057 | pubmed:meshHeading | pubmed-meshheading:3493057-... | lld:pubmed |
| pubmed-article:3493057 | pubmed:meshHeading | pubmed-meshheading:3493057-... | lld:pubmed |
| pubmed-article:3493057 | pubmed:meshHeading | pubmed-meshheading:3493057-... | lld:pubmed |
| pubmed-article:3493057 | pubmed:meshHeading | pubmed-meshheading:3493057-... | lld:pubmed |
| pubmed-article:3493057 | pubmed:meshHeading | pubmed-meshheading:3493057-... | lld:pubmed |
| pubmed-article:3493057 | pubmed:meshHeading | pubmed-meshheading:3493057-... | lld:pubmed |
| pubmed-article:3493057 | pubmed:meshHeading | pubmed-meshheading:3493057-... | lld:pubmed |
| pubmed-article:3493057 | pubmed:meshHeading | pubmed-meshheading:3493057-... | lld:pubmed |
| pubmed-article:3493057 | pubmed:year | 1987 | lld:pubmed |
| pubmed-article:3493057 | pubmed:articleTitle | Treatment of experimental allergic neuritis with prednisolone. | lld:pubmed |
| pubmed-article:3493057 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:3493057 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3493057 | lld:pubmed |
